Ocean Biomedical, Inc.

Ocean Biomedical, Inc. is associated with Aesther Healthcare Acquisition Corp, a blank-check company trading under the ticker AEHA that completed its initial public offering in 2021 with a focus on the healthcare and life sciences sector. Sponsored by Aesther Healthcare Holdings LLC, the SPAC targeted opportunities in biomedical innovation, ultimately announcing a business combination with Ocean Biomedical, a Providence, Rhode Island-based company developing therapeutics for oncology, infectious disease, and pulmonary arterial hypertension derived in part from ocean-based biological research. The 10-Q filed on April 25, 2022 reflects the company's reporting obligations during the de-SPAC transition period. Sign up at SpacDesk for full filing history, deal timelines, and sponsor data on AEHA and hundreds of other SPAC transactions.